nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of iatrogenic vitamin D toxicity revealed by drug reconciliation
|
Mouton Sclaunich, Hugo |
|
|
77 |
3 |
p. 388-390 |
artikel |
2 |
Analyse des prescriptions hospitalières hors AMM des médicaments chez l’adulte et étude de la faisabilité de leur détection par le codage CIM-10 du PMSI
|
Gault, Nathalie |
|
|
77 |
3 |
p. 329-338 |
artikel |
3 |
Androgens, QT, sex and ventricular repolarization
|
Alexandre, Joachim |
|
|
77 |
3 |
p. 257-258 |
artikel |
4 |
Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series
|
Moey, Melissa Y.Y. |
|
|
77 |
3 |
p. 265-271 |
artikel |
5 |
Application of benvitimod on psoriasis: A systematic review and meta-analysis of randomized controlled trials. A systematic review of benvitimod on psoriasis
|
Chen, Lianghong |
|
|
77 |
3 |
p. 339-347 |
artikel |
6 |
Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers
|
Chouchana, Laurent |
|
|
77 |
3 |
p. 371-373 |
artikel |
7 |
Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide
|
Bérard, Mathilde |
|
|
77 |
3 |
p. 386-388 |
artikel |
8 |
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic
|
Lory, Pauline |
|
|
77 |
3 |
p. 301-307 |
artikel |
9 |
Editorial board
|
|
|
|
77 |
3 |
p. i |
artikel |
10 |
Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients
|
Pala, Emin |
|
|
77 |
3 |
p. 361-369 |
artikel |
11 |
Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data
|
Tissot, Marion |
|
|
77 |
3 |
p. 291-300 |
artikel |
12 |
General practitioners’ compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey
|
Singier, Allison |
|
|
77 |
3 |
p. 349-359 |
artikel |
13 |
Global research output in ‘pharmacovigilance’ during 2010–2020
|
Tyagi, Sunil |
|
|
77 |
3 |
p. 273-290 |
artikel |
14 |
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
|
Shah, Jagat Narayan |
|
|
77 |
3 |
p. 319-328 |
artikel |
15 |
Pharmacovigilance and drug safety: Fair prescribing and clinical research
|
Montastruc, Jean-Louis |
|
|
77 |
3 |
p. 261-263 |
artikel |
16 |
Prise en charge de l’hypersensibilité immédiate aux β-lactamines : étude rétrospective au centre de pharmacovigilance de Sfax
|
Ghozzi, Hanène |
|
|
77 |
3 |
p. 375-378 |
artikel |
17 |
À propos de la prévention des conflits d’intérêts
|
Lagarrigue, Jacques |
|
|
77 |
3 |
p. 259-260 |
artikel |
18 |
Prévalence des prescriptions des statines chez les personnes âgées des EHPAD de l’Occitanie Ouest
|
Zacarin, Alice |
|
|
77 |
3 |
p. 384-386 |
artikel |
19 |
Quétiapine et hypersexualité : à propos de deux cas
|
Meyer, Guillaume |
|
|
77 |
3 |
p. 381-384 |
artikel |
20 |
Raising public awareness about the misuse of predatory journals: One year after the “hydroxychloroquine and push-scooters accidents” hoax
|
Rebeaud, Mathieu E. |
|
|
77 |
3 |
p. 373-375 |
artikel |
21 |
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports
|
Braesch, Clément |
|
|
77 |
3 |
p. 378-381 |
artikel |
22 |
Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants
|
Barbaroux, Adriaan |
|
|
77 |
3 |
p. 309-317 |
artikel |